D-Index & Metrics Best Publications
Medicine
Canada
2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 128 Citations 72,057 999 World Ranking 1513 National Ranking 48

Research.com Recognitions

Awards & Achievements

2023 - Research.com Medicine in Canada Leader Award

2009 - Fellow of the Royal Society of Canada Academy of Science

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Disease

His primary areas of investigation include Acquired immunodeficiency syndrome, Immunology, Internal medicine, Viral load and Substance abuse. His Acquired immunodeficiency syndrome research incorporates elements of Viral disease, Mortality rate, Psychiatry, Pharmacotherapy and Intensive care medicine. The Immunology study combines topics in areas such as Epidemiology, Incidence and Antiretroviral therapy.

The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Sida and Surgery. His biological study spans a wide range of topics, including Proportional hazards model and Drug resistance. His study in Substance abuse is interdisciplinary in nature, drawing from both Gerontology, Cohort study, Family medicine, SAFER and Drug.

His most cited work include:

  • Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection (1943 citations)
  • Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. (1123 citations)
  • Treatment for adult HIV infection : 2006 recommendations of the international AIDS society-USA panel (993 citations)

What are the main themes of his work throughout his whole career to date?

Julio S. G. Montaner focuses on Acquired immunodeficiency syndrome, Internal medicine, Immunology, Cohort and Demography. His research integrates issues of Epidemiology, Gerontology and Public health in his study of Acquired immunodeficiency syndrome. His Internal medicine study often links to related topics such as Viral load.

His Immunology research is multidisciplinary, relying on both Chemotherapy, Oncology and Drug resistance. The study incorporates disciplines such as Odds ratio, Cohort study, Psychiatry, Multivariate analysis and Prospective cohort study in addition to Cohort. His Demography research is multidisciplinary, incorporating perspectives in Men who have sex with men and Incidence.

He most often published in these fields:

  • Acquired immunodeficiency syndrome (41.58%)
  • Internal medicine (35.52%)
  • Immunology (26.31%)

What were the highlights of his more recent work (between 2015-2021)?

  • Acquired immunodeficiency syndrome (41.58%)
  • Demography (25.73%)
  • Cohort (31.12%)

In recent papers he was focusing on the following fields of study:

Julio S. G. Montaner mainly investigates Acquired immunodeficiency syndrome, Demography, Cohort, Viral load and Internal medicine. His Acquired immunodeficiency syndrome research is multidisciplinary, incorporating elements of Psychological intervention, Epidemiology, Gerontology, Environmental health and Public health. His work in Demography addresses issues such as Confidence interval, which are connected to fields such as Odds ratio and Antiretroviral therapy.

His biological study deals with issues like Psychiatry, which deal with fields such as HIV-positive people. His Viral load study necessitates a more in-depth grasp of Immunology. His research in Internal medicine focuses on subjects like Ritonavir, which are connected to Atazanavir.

Between 2015 and 2021, his most popular works were:

  • Near real-time monitoring of HIV transmission hotspots from routine HIV genotyping: an implementation case study (107 citations)
  • HIV and the criminalisation of drug use among people who inject drugs: a systematic review (77 citations)
  • How Generalizable Are the Results From Trials of Direct Antiviral Agents to People Coinfected With HIV/HCV in the Real World? (56 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Disease

Demography, Acquired immunodeficiency syndrome, Cohort, Confidence interval and Gerontology are his primary areas of study. Julio S. G. Montaner interconnects Odds ratio, Logistic regression, Treatment as prevention, Injection drug use and Prospective cohort study in the investigation of issues within Demography. His work deals with themes such as Mortality rate, Internal medicine, Incidence and Harm reduction, Public health, which intersect with Acquired immunodeficiency syndrome.

His Internal medicine study combines topics from a wide range of disciplines, such as Immunology and Drug resistance. His Cohort research incorporates themes from Psychiatry, Cohort study, Viral load and Heroin. Julio S. G. Montaner focuses mostly in the field of Confidence interval, narrowing it down to topics relating to Proportional hazards model and, in certain cases, Hazard ratio.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection

Richard K. Sterling;Eduardo Lissen;Eduardo Lissen;Nathan Clumeck;Ricard Sola.
Hepatology (2006)

3235 Citations

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.

Francesca J. Torriani;Maribel Rodriguez-Torres;Jürgen K. Rockstroh;Eduardo Lissen.
The New England Journal of Medicine (2004)

1705 Citations

Antiretroviral Therapy in Adults: Updated Recommendations of the International AIDS Society–USA Panel

Charles C. J. Carpenter;David A. Cooper;Margaret A. Fischl;Jose M. Gatell.
JAMA (2000)

1382 Citations

Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America.

Jacob P. Lalezari;Keith Henry;Mary O'Hearn;Julio S.G. Montaner.
The New England Journal of Medicine (2003)

1179 Citations

Treatment for adult HIV infection : 2006 recommendations of the international AIDS society-USA panel

Scott M. Hammer;Michael S. Saag;Mauro Schechter;Julio S. G. Montaner.
JAMA (2006)

1134 Citations

Improved Survival Among HIV-Infected Individuals Following Initiation of Antiretroviral Therapy

Robert S. Hogg;Katherine V. Heath;Benita Yip;Kevin J. P. Craib.
JAMA (1998)

1078 Citations

A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study.

Julio S. G. Montaner;Peter Reiss;David Cooper;Stefano Vella.
JAMA (1998)

1047 Citations

Antiretroviral Therapy for HIV Infection in 1997: Updated Recommendations of the International AIDS Society—USA Panel

Charles C. J. Carpenter;Margaret A. Fischl;Scott M. Hammer;Martin S. Hirsch.
JAMA (1997)

988 Citations

Antiretroviral Treatment for Adult HIV Infection in 2002: Updated Recommendations of the International AIDS Society-USA Panel

Patrick G. Yeni;Scott M. Hammer;Charles C. J. Carpenter;David A. Cooper.
JAMA (2002)

985 Citations

Rates of Disease Progression by Baseline CD4 Cell Count and Viral Load After Initiating Triple-Drug Therapy

Robert S. Hogg;Benita Yip;Keith J. Chan;Evan Wood.
JAMA (2001)

984 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Julio S. G. Montaner

Thomas Kerr

Thomas Kerr

University of British Columbia

Publications: 499

Evan Wood

Evan Wood

University of British Columbia

Publications: 396

Robert S. Hogg

Robert S. Hogg

Simon Fraser University

Publications: 229

Steffanie A. Strathdee

Steffanie A. Strathdee

University of California, San Diego

Publications: 220

Vincent Soriano

Vincent Soriano

Hospital Universitario La Paz

Publications: 173

Kenneth H. Mayer

Kenneth H. Mayer

Fenway Health

Publications: 170

Andrew N. Phillips

Andrew N. Phillips

University College London

Publications: 163

Frederick L. Altice

Frederick L. Altice

Yale University

Publications: 152

Richard D. Moore

Richard D. Moore

Johns Hopkins University

Publications: 139

David A. Cooper

David A. Cooper

University of New South Wales

Publications: 139

Amy C. Justice

Amy C. Justice

Yale University

Publications: 131

Jens D. Lundgren

Jens D. Lundgren

Rigshospitalet

Publications: 129

Marina B. Klein

Marina B. Klein

University of British Columbia

Publications: 127

David R. Bangsberg

David R. Bangsberg

VinUniversity

Publications: 126

Kate Shannon

Kate Shannon

University of British Columbia

Publications: 126

Michael S. Saag

Michael S. Saag

University of Alabama at Birmingham

Publications: 125

Trending Scientists

Li-wei He

Li-wei He

Airbnb

Justin Paul

Justin Paul

University of Puerto Rico

Steven Gao

Steven Gao

University of Kent

Tamar Flash

Tamar Flash

Weizmann Institute of Science

Wiley J. Youngs

Wiley J. Youngs

University of Akron

Nobuaki Koga

Nobuaki Koga

Nagoya University

Carlo Nike Bianchi

Carlo Nike Bianchi

University of Genoa

C. R. Krehbiel

C. R. Krehbiel

University of Nebraska–Lincoln

Freddy Radtke

Freddy Radtke

École Polytechnique Fédérale de Lausanne

Sacha A. F. T. van Hijum

Sacha A. F. T. van Hijum

KPMG (Netherlands)

Reuben J. Peters

Reuben J. Peters

Iowa State University

Ben Lopman

Ben Lopman

Emory University

Kees Meliefste

Kees Meliefste

Utrecht University

Scot T. Martin

Scot T. Martin

Harvard University

Márta Korbonits

Márta Korbonits

Queen Mary University of London

Something went wrong. Please try again later.